Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates

Journey Medical Corporation (DERM) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of$ 0.24. This compares to loss of $0.53 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 25%. A quarter ago, it was expected that this company would post a loss of$ 0.22 per share when it actually produced earnings of $0.08, delivering a surprise of 136.36%.Over the last four quarters, the company ...